<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background:Although family history is well established to be a risk factor for developing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), much less is known about its impact on patient survival </plain></SENT>
<SENT sid="1" pm="."><plain>This study aimed to link <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patient data from the National Study of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal Cancer</z:e> Genetics (NSCCG) to the National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Data Repository (NCDR) to examine the relationship between family history and the characteristics and outcomes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>.Methods:<z:hpo ids='HP_0000001'>All</z:hpo> eligible NSCCG patients underwent a matching process to the NCDR using combinations of their personal identifiers </plain></SENT>
<SENT sid="2" pm="."><plain>The characteristics and survival of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients with and without a family history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> were compared.Results:Of the 10 937 NSCCG patients eligible to be matched into the NCDR, 10 782 (98.6%) could be fully linked </plain></SENT>
<SENT sid="3" pm="."><plain>There were no significant differences between those with and without a family history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (defined as having at least one affected first-degree relative) in terms of age, sex, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> stage at diagnosis, presence of <z:e sem="disease" ids="C0346429" disease_type="Neoplastic Process" abbrv="">multiple cancers</z:e>, mode of presentation to hospital and surgical management, although patients with familial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> were more likely to have right-sided <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (P&lt;0.01) </plain></SENT>
<SENT sid="4" pm="."><plain>The survival of patients with familial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> was significantly better than those with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (HR 0.89, 95%CI: 0.81-0.98, P=0.02).Conclusion:We have demonstrated that it is possible to robustly match patients recruited into the NSCCG into the NCDR and, by using this record linkage, enable genetic data to be related to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> phenotype, clinical management and outcome </plain></SENT>
<SENT sid="5" pm="."><plain>This study provides evidence that a family history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> is associated with better survival after a diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>.British Journal of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> advance online publication, 19 March 2013; doi:10.1038/bjc.2013.91 www.bjcancer.com </plain></SENT>
</text></document>